Regulators, Bristol-myers | featured news

FDA questions safety of experimental diabetes drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...

 

Subscribe to this RSS topic: Syndicate content